We are pleased to announce the successful completion of an institutional placement for Alcidion of 90 million shares, raising a total of $16.2 million. We acted as lead manager to the placement.
Alcidion is transforming healthcare with smart, intuitive technology solutions that meet the needs of hospital and allied healthcare worldwide. Their suite of software products and services create a unique offering in the global healthcare market.
The funds will be used to accelerate the company’s growth strategy through investment in sales, marketing and clinical support resources to underpin market adoption in its three key geographic markets; the UK, Australia and New Zealand.
To support this growth, funds will additionally be invested to further strengthen the Miya Precision platform. Miya Precision combines AI-based predictive analytics, Clinical Decision Support (CDS) and mobile alerts in one easy-to-use dashboard.
The placement saw strong support from new and existing institutional investors, bringing several leading institutions onto Alcidion’s share register as cornerstone investors.
“Alcidion is well-placed to scale up and pursue a significant global market opportunity. The adoption of technology in healthcare is accelerating, driven by access to digital patient data, increasing demands on healthcare and a shifting regulatory environment.
Kate Quirke, Managing Director of Alcidion
We are excited to continue working closely with Alcidion as they strive towards making healthcare safer and more efficient for all.
To discuss this transaction and how the Henslow team can assist your business, please contact Justin Lewis (firstname.lastname@example.org).